Search Results Search Sort by RelevanceMost Recent Case and Commentary Dec 2018 When Should Iatrogenic Polypharmacy Be Considered a Disease? Christine Wieseler, PhD When symptoms of polypharmacy are consistent with those of difficult-to-diagnose disorders, reliable determinations about which drugs are necessary is critical. AMA J Ethics. 2018;20(12):E1133-1138. doi: 10.1001/amajethics.2018.1133. Personal Narrative Jul 2022 Imprints of “Scanxiety” Rachel Mindrup, MFA The days leading up to and waiting for the results of magnetic resonance imaging sessions are anxiety-inducing. AMA J Ethics. 2022;24(7):E685-693. doi: 10.1001/amajethics.2022.685. Podcast Jul 2022 Author Interview: “Imprints of ‘Scanxiety’” Rachel Mindrup joins Ethics Talk to discuss her article: “Imprints of ‘Scanxiety.’”
Case and Commentary Dec 2018 When Should Iatrogenic Polypharmacy Be Considered a Disease? Christine Wieseler, PhD When symptoms of polypharmacy are consistent with those of difficult-to-diagnose disorders, reliable determinations about which drugs are necessary is critical. AMA J Ethics. 2018;20(12):E1133-1138. doi: 10.1001/amajethics.2018.1133.
Personal Narrative Jul 2022 Imprints of “Scanxiety” Rachel Mindrup, MFA The days leading up to and waiting for the results of magnetic resonance imaging sessions are anxiety-inducing. AMA J Ethics. 2022;24(7):E685-693. doi: 10.1001/amajethics.2022.685.
Podcast Jul 2022 Author Interview: “Imprints of ‘Scanxiety’” Rachel Mindrup joins Ethics Talk to discuss her article: “Imprints of ‘Scanxiety.’”